Filing Details
- Accession Number:
- 0001562180-18-000299
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-12 16:07:59
- Reporting Period:
- 2018-01-10
- Accepted Time:
- 2018-01-12 16:07:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612859 | Stephen Kanes | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-10 | 600 | $170.67 | 46,348 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 1,200 | $171.80 | 45,148 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 1,200 | $173.09 | 43,948 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 2,200 | $174.35 | 41,748 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 2,461 | $175.03 | 39,287 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 11,057 | $176.53 | 28,230 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 9,100 | $177.48 | 19,130 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 6,923 | $178.33 | 12,207 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 7,859 | $179.61 | 4,348 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-10 | 1,400 | $180.11 | 2,948 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-12 | 20,000 | $0.45 | 22,948 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-12 | 20,000 | $0.00 | 20,000 | $0.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 111,432 | 2023-07-23 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $170.12 USD to $171.02 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $171.41 USD to $172.27 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $172.68 USD to $173.49 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $173.73 USD to $174.72 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $174.84 USD to $175.78 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $175.94 USD to $176.84 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $176.99 USD to $177.98 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $177.99 USD to $178.89 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $178.99 USD to $179.98 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $179.99 USD to $180.44 USD. The price reported above reflects the weighted average sale price.
- The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option fully vested on July 18, 2017, subject to continued service through such date.
Billionaire Hedge Funds
